We are live on
!
Find out more
TCIM
TIAA CREF Investment Management Portfolio holdings
AUM
$141B
1-Year Est. Return
14.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.42%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.08%
5 Year Est. Return
+108.37%
10 Year Est. Return
–
AUM
$153B
AUM Growth
+$4.35B
(+2.9%)
Cap. Flow
-$5.76B
Cap. Flow
% of AUM
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
20.07%
Holding
3,135
New
52
Increased
771
Reduced
2,179
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$201M |
| 2 |
Procter & Gamble
PG
|
+$170M |
| 3 |
Eli Lilly
LLY
|
+$164M |
| 4 |
Constellation Brands
STZ
|
+$137M |
| 5 |
Gilead Sciences
GILD
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$362M |
| 2 |
Goldman Sachs
GS
|
+$310M |
| 3 |
Applied Materials
AMAT
|
+$235M |
| 4 |
Intel
INTC
|
+$207M |
| 5 |
Oracle
ORCL
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.89% |
| 2 | Financials | 14.63% |
| 3 | Healthcare | 14.23% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Industrials | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
National Bankshares
NKSH
$257M
| $672K | ﹤0.01% |
14,788
-445
| -3% | -$20.7K |
|
|
TTOO
2602
DELISTED
T2 Biosystems, Inc
TTOO
| $671K | ﹤0.01% |
18
-1
| -5% | -$32.9K |
|
|
XELA
2603
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $671K | ﹤0.01% |
8
-2
| -20% | -$135K |
|
|
AMNB
2604
DELISTED
American National Bankshares Inc
AMNB
| $671K | ﹤0.01% |
17,197
-681
| -4% | -$27.7K |
|
2605
Arbutus Biopharma
ABUS
$907M
| $665K | ﹤0.01% |
70,359
-8,087
| -10% | -$80.3K |
|
2606
Powell Industries
POWL
$7.55B
| $664K | ﹤0.01% |
54,915
-8,445
| -13% | -$105K |
|
|
WOW
2607
DELISTED
WideOpenWest
WOW
| $664K | ﹤0.01% |
59,197
-2,627
| -4% | -$29.4K |
|
|
AVEO
2608
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $663K | ﹤0.01% |
20,042
-2,536
| -11% | -$65.2K |
|
2609
Utah Medical Products
UTMD
$227M
| $662K | ﹤0.01% |
7,028
-290
| -4% | -$27.7K |
|
2610
Innovative Industrial Properties
IIPR
$1.66B
| $660K | ﹤0.01% |
13,680
-584
| -4% | -$22.3K |
|
|
ADVM
2611
DELISTED
Adverum Biotechnologies
ADVM
| $658K | ﹤0.01% |
10,871
-1,224
| -10% | -$68.7K |
|
|
HONE
2612
DELISTED
HarborOne Bancorp
HONE
| $656K | ﹤0.01% |
61,628
+5,791
| +10% | +$61.6K |
|
|
CATC
2613
DELISTED
CAMBRIDGE BANCORP
CATC
| $656K | ﹤0.01% |
7,288
-914
| -11% | -$82.2K |
|
2614
Inspire Medical Systems
INSP
$1.73B
| $652K | ﹤0.01% |
15,490
-1,916
| -11% | -$89.9K |
|
2615
First Internet Bancorp
INBK
$256M
| $648K | ﹤0.01% |
21,291
+5,092
| +31% | +$162K |
|
2616
Rush Enterprises Class B
RUSHB
$9.1B
| $643K | ﹤0.01% |
36,245
-534
| -1% | -$10.4K |
|
|
XXII
2617
22nd Century Group
XXII
$1.5M
| – | – |
0
| – | – |
|
|
FRBK
2618
DELISTED
Republic First Bancorp Inc
FRBK
| $640K | ﹤0.01% |
89,551
-17,040
| -16% | -$130K |
|
2619
CryoPort
CYRX
$751M
| $636K | ﹤0.01% |
49,669
-5,879
| -11% | -$83.9K |
|
|
PHX
2620
DELISTED
PHX Minerals
PHX
| $633K | ﹤0.01% |
34,307
-8,437
| -20% | -$163K |
|
2621
HCI Group
HCI
$2.3B
| $632K | ﹤0.01% |
14,440
-2,875
| -17% | -$119K |
|
2622
Civista Bancshares
CIVB
$585M
| $631K | ﹤0.01% |
26,183
+4,101
| +19% | +$100K |
|
2623
TG Therapeutics
TGTX
$7.52B
| $630K | ﹤0.01% |
112,459
-11,965
| -10% | -$137K |
|
2624
FreightCar America
RAIL
$259M
| $628K | ﹤0.01% |
39,103
-1,387
| -3% | -$23.9K |
|
2625
Home Bancorp
HBCP
$556M
| $627K | ﹤0.01% |
14,409
-1,532
| -10% | -$69.7K |
|
Similar funds
TA
O
HFS
SBAM
BB
SA
WF
BCPEM
TIAA CREF Investment Management's Q3 2018 Portfolio in Review
As of Q3 2018, TIAA CREF Investment Management held 3,135 positions worth $153B, up 2.9% from $149B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
TIAA CREF Investment Management withdrew a net $5.76B in Q3 2018, closing 81 positions and reducing 2,179 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $137M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TIAA CREF Investment Management opened a new position in Bombardier Recreational Products worth $71M.
- TIAA CREF Investment Management's largest Q3 2018 buy was Bombardier Recreational Products: 1,515,417 shares worth $71M.
- TIAA CREF Investment Management added most to Merck in Q3 2018, an estimated $201M increase.
- TIAA CREF Investment Management's biggest Q3 2018 reduction was Broadcom, cutting an estimated $362M.
- TIAA CREF Investment Management fully exited iShares Russell 1000 Growth ETF in Q3 2018, selling an estimated $137M.
- TIAA CREF Investment Management's ten largest holdings make up 20% of its $153B portfolio in Q3 2018.
- TIAA CREF Investment Management opened 52 new positions and closed 81 in Q3 2018.
- TIAA CREF Investment Management's portfolio value rose 2.9% quarter-over-quarter to $153B.
Based on TIAA CREF Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.